\
&
Contact us
\
&
Contact us
This was 5 months ago
LocationOnline
ProgrammesThe European Partnership for Personalised Medicine has just launched a new opportunity for start-ups, researchers and early-stage teams working on cutting-edge solutions in personalised medicine.
EP PerMed Fast Track Validation Programme has been designed to address a key challenge in the development of personalised medicine (PM) solutions: the validation phase. Transitioning innovative concepts into market-ready products requires thorough validation to ensure they align with the needs and expectations of end-users, including clinicians and patients.
The Fast Track Validation Programme provides a structured and accelerated pathway for PM innovators to successfully validate their solutions. In this webinar, EP PerMed will offer an overview of the programme, its requirements, and the application and support process, providing key insights for those interested in applying.
More information and registration here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Atlas Integratie & Inburgering Antwerpen is an autonomous agency and a non-profit organisation responsible for implementing the Flemish integration policy on behalf of and for the City of Antwerp. Atlas offers several types of services for newcomers and Antwerp’s public and non-profit organisations.
In 2018, under the leadership of HafenCity University Hamburg, Atlas participated in the H2020 call 'Addressing the challenge of migrant integration through ICT-enabled solutions'. The proposal 'MICADO - Migrant Integration Cockpits and Dashboards' was approved by the European Commission and the project started in January 2019 and runs until June 2022.
